Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises '21 View

Published on November 3, 2021

Vertex Pharmaceuticals' (VRTX) earnings and sales beat estimates for the third quarter of 2021. The company raises its product revenue guidance for the year.

Continue reading on website
Other news

Capri Holdings' (CPRI) Q2 Earnings Top Estimates, FY22 View Up

November 3, 2021
Capri Holdings' (CPRI) second-quarter results reflect better revenue performance across all three luxury houses. Management now envisions revenues to be approximately $5.4 billion for fiscal 2022.

Amdocs' (DOX) Earnings and Revenues Miss Estimates in Q4

November 3, 2021
Amdocs' (DOX) fiscal fourth-quarter 2021 results reflect benefits from its core businesses and Sourced, ADK and Clearbridge acquisitions.